Sommaire
Littérature scientifique sur le sujet « Trehalase inhibitors »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Trehalase inhibitors ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Articles de revues sur le sujet "Trehalase inhibitors"
White, Christopher, Deborah B. Lee et Stephen J. Free. « NEUROSPORA TREHALASE AND ITS STRUCTURAL GENE ». Genetics 110, no 2 (1 juin 1985) : 217–27. http://dx.doi.org/10.1093/genetics/110.2.217.
Texte intégralMatassini, Camilla, Camilla Parmeggiani et Francesca Cardona. « New Frontiers on Human Safe Insecticides and Fungicides : An Opinion on Trehalase Inhibitors ». Molecules 25, no 13 (1 juillet 2020) : 3013. http://dx.doi.org/10.3390/molecules25133013.
Texte intégralMarten, Andrew D., Alicyn I. Stothard, Karishma Kalera, Benjamin M. Swarts et Michael J. Conway. « Validamycin A Delays Development and Prevents Flight in Aedes aegypti (Diptera : Culicidae) ». Journal of Medical Entomology 57, no 4 (26 janvier 2020) : 1096–103. http://dx.doi.org/10.1093/jme/tjaa004.
Texte intégralStreeter, J. G., et M. L. Gomez. « Three Enzymes for Trehalose Synthesis in Bradyrhizobium Cultured Bacteria and in Bacteroids from Soybean Nodules ». Applied and Environmental Microbiology 72, no 6 (juin 2006) : 4250–55. http://dx.doi.org/10.1128/aem.00256-06.
Texte intégralKAMEDA, YUKIHIKO, NAOKI ASANO, TAKUJI YAMAGUCHI et KATSUHIKO MATSUI. « Validoxylamines as trehalase inhibitors. » Journal of Antibiotics 40, no 4 (1987) : 563–65. http://dx.doi.org/10.7164/antibiotics.40.563.
Texte intégralBini, Davide, Francesca Cardona, Matilde Forcella, Camilla Parmeggiani, Paolo Parenti, Francesco Nicotra et Laura Cipolla. « Synthesis and biological evaluation of nojirimycin- and pyrrolidine-based trehalase inhibitors ». Beilstein Journal of Organic Chemistry 8 (5 avril 2012) : 514–21. http://dx.doi.org/10.3762/bjoc.8.58.
Texte intégralKyosseva, S. V., Z. N. Kyossev et A. D. Elbein. « Inhibitors of Pig Kidney Trehalase ». Archives of Biochemistry and Biophysics 316, no 2 (février 1995) : 821–26. http://dx.doi.org/10.1006/abbi.1995.1110.
Texte intégralQIAN, XUHONG, ZHIBIN LI, ZHI LIU, GONGHUA SONG et ZHONG LI. « Syntheses of 2-Aryliminooxazolidine Derivatives as Trehalase Inhibitors. » Journal of Antibiotics 54, no 12 (2001) : 1108–10. http://dx.doi.org/10.7164/antibiotics.54.1108.
Texte intégralGibson, Robert P, Tracey M Gloster, Shirley Roberts, R. Anthony J Warren, Isabel Storch de Gracia, Ángela García, Jose L Chiara et Gideon J Davies. « Molecular Basis for Trehalase Inhibition Revealed by the Structure of Trehalase in Complex with Potent Inhibitors ». Angewandte Chemie 119, no 22 (25 mai 2007) : 4193–97. http://dx.doi.org/10.1002/ange.200604825.
Texte intégralGibson, Robert P, Tracey M Gloster, Shirley Roberts, R. Anthony J Warren, Isabel Storch de Gracia, Ángela García, Jose L Chiara et Gideon J Davies. « Molecular Basis for Trehalase Inhibition Revealed by the Structure of Trehalase in Complex with Potent Inhibitors ». Angewandte Chemie International Edition 46, no 22 (25 mai 2007) : 4115–19. http://dx.doi.org/10.1002/anie.200604825.
Texte intégralThèses sur le sujet "Trehalase inhibitors"
BINI, DAVIDE. « Synthesis of Glycoconjugates and their Analogs for the Study of Biological Systems ». Doctoral thesis, Università degli Studi di Milano-Bicocca, 2016. http://hdl.handle.net/10281/103143.
Texte intégralThanna, Sandeep. « Design and Synthesis of Novel Inhibitors for Enzymatic Targets in Trehalose Utilization Pathways of Mycobacterium tuberculosis ». University of Toledo / OhioLINK, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=toledo1501627900249048.
Texte intégralHuang, Yin-Jung, et 黃胤榮. « Functional expression of human trehalase in Escherichia coli and identification of novel trehalase inhibitors ». Thesis, 2013. http://ndltd.ncl.edu.tw/handle/95603406888333667888.
Texte intégral國立臺灣師範大學
生命科學研究所
101
In mammals, trehalase, sucrase-isomaltase and maltase-glucoamylase are the major α-glycosidases of the intestinal brush border membranes. These enzymes are responsible for the degradation of di- and oligosaccharides into monosaccharides, and are crucial for the energy-intake. Trehalase (EC 3.2.1.28) hydrolyses α,α-trehalose (1-α-D-glucopyranosyl α-D-glucopyranoside) to two glucose molecules. The intestinal trehalase is involved in the hydrolysis of ingested trehalose which is found mainly in many nutrient foods. The dual protective properties of trehalose (as a chemical chaperone and an inducer of autophagy) have encouraged pharmaceutical application of the disaccharide in neurodegenerative diseases caused by protein aggregation process. Therefore, it is theoretically possible to increase intestinal absorption of trehalose through inhibiting intestinal trehalase activity, and thus increase in trehalose content in blood or brain. This may in turn alleviate neurological protein deposition diseases. The protein structure, catalytic mechanism and specific inhibitors of human intestinal trehalase (hTreH) have not been elucidated. In the present study, a cDNA fragment encoding the mature form of hTreH was cloned and recombinant hTreH was expressed in Escherichia coli. However,the recombinant hTreH was expressed as an inclusion body. Protein refolding through dialysis and on-column refolding process were performed. The refolded enzyme showed very low specific activity. To prevent protein misfolding through the formation of incorrect intra- or inter-molecular disulfide bonds and thus increase its solubility, based on tertiary structure modeling, several predicted non-disulfide-bonding cysteine residues in hTreH were replaced with serine by site-directed mutagenesis. Four cysteine residues in hTreH were changed into serine, which are predicted to be distant from each other and may not form disulfide bonds with each other. However, the mutant proteins were also expressed as inclusion bodies, and the refolded enzymes still showed no activity. Several trehalose analogs were biochemically characterized as mammalian trehalase inhibitors, and they can be as potential therapeutics for the protein deposition-mediated diseases. Keyword: trehalose, trehalase, trehalase inhibitor, recombinant protein expression
Miao, Yi. « Structural and Biochemical Dissection of the Trehalose Biosynthetic Complex in Pathogenic Fungi ». Diss., 2016. http://hdl.handle.net/10161/12130.
Texte intégralTrehalose is a non-reducing disaccharide essential for pathogenic fungal survival and virulence. The biosynthesis of trehalose requires the trehalose-6-phosphate synthase, Tps1, and trehalose-6-phosphate phosphatase, Tps2. More importantly, the trehalose biosynthetic pathway is absent in mammals, conferring this pathway as an ideal target for antifungal drug design. However, lack of germane biochemical and structural information hinders antifungal drug design against these targets.
In this dissertation, macromolecular X-ray crystallography and biochemical assays were employed to understand the structures and functions of proteins involved in the trehalose biosynthetic pathway. I report here the first eukaryotic Tps1 structures from Candida albicans (C. albicans) and Aspergillus fumigatus (A. fumigatus) with substrates or substrate analogs. These structures reveal the key residues involved in substrate binding and catalysis. Subsequent enzymatic assays and cellular assays highlight the significance of these key Tps1 residues in enzyme function and fungal stress response. The Tps1 structure captured in its transition-state with a non-hydrolysable inhibitor demonstrates that Tps1 adopts an “internal return like” mechanism for catalysis. Furthermore, disruption of the trehalose biosynthetic complex formation through abolishing Tps1 dimerization reveals that complex formation has regulatory function in addition to trehalose production, providing additional targets for antifungal drug intervention.
I also present here the structure of the Tps2 N-terminal domain (Tps2NTD) from C. albicans, which may be involved in the proper formation of the trehalose biosynthetic complex. Deletion of the Tps2NTD results in a temperature sensitive phenotype. Further, I describe in this dissertation the structures of the Tps2 phosphatase domain (Tps2PD) from C. albicans, A. fumigatus and Cryptococcus neoformans (C. neoformans) in multiple conformational states. The structures of the C. albicans Tps2PD -BeF3-trehalose complex and C. neoformans Tps2PD(D24N)-T6P complex reveal extensive interactions between both glucose moieties of the trehalose involving all eight hydroxyl groups and multiple residues of both the cap and core domains of Tps2PD. These structures also reveal that steric hindrance is a key underlying factor for the exquisite substrate specificity of Tps2PD. In addition, the structures of Tps2PD in the open conformation provide direct visualization of the conformational changes of this domain that are effected by substrate binding and product release.
Last, I present the structure of the C. albicans trehalose synthase regulatory protein (Tps3) pseudo-phosphatase domain (Tps3PPD) structure. Tps3PPD adopts a haloacid dehydrogenase superfamily (HADSF) phosphatase fold with a core Rossmann-fold domain and a α/β fold cap domain. Despite lack of phosphatase activity, the cleft between the Tps3PPD core domain and cap domain presents a binding pocket for a yet uncharacterized ligand. Identification of this ligand could reveal the cellular function of Tps3 and any interconnection of the trehalose biosynthetic pathway with other cellular metabolic pathways.
Combined, these structures together with significant biochemical analyses advance our understanding of the proteins responsible for trehalose biosynthesis. These structures are ready to be exploited to rationally design or optimize inhibitors of the trehalose biosynthetic pathway enzymes. Hence, the work described in this thesis has laid the groundwork for the design of Tps1 and Tps2 specific inhibitors, which ultimately could lead to novel therapeutics to treat fungal infections.
Dissertation
Chapitres de livres sur le sujet "Trehalase inhibitors"
El Nemr, Ahmed, et El Sayed H. El Ashry. « Potential trehalase inhibitors ». Dans Advances in Carbohydrate Chemistry and Biochemistry, 45–114. Elsevier, 2011. http://dx.doi.org/10.1016/b978-0-12-385520-6.00003-0.
Texte intégral